08 February 2023 : Database Analysis
High SPATA18 Expression and its Diagnostic and Prognostic Value in Clear Cell Renal Cell Carcinoma
Xie Lingui1ACE, Liu Weifeng1BC, Wang Yufei1B, Zhou Yibin1AFG*DOI: 10.12659/MSM.938474
Med Sci Monit 2023; 29:e938474
Table 2 Characteristics of renal cell carcinoma classified by SPATA18 expression.
| Characteristic (n=21) | SPATA18 | |
|---|---|---|
| Low6 (28.6%) | High15 (71.4%) | |
| Age | ||
| <60 | 3 (50%) | 7 (46.7%) |
| ≥60 | 3 (50%) | 8 (53.3%) |
| Sex | ||
| Male | 6 (100%) | 9 (60%) |
| Female | 0 | 6 (40%) |
| Tumor location | ||
| Right-sided colon | 4 (66.7%) | 5 (33.3%) |
| Left-sided colon | 2 (33.3%) | 10 (66.7%) |
| WHO/ISUP | ||
| Well to moderately | 3 (50%) | 5 (33.3%) |
| Poorly | 3 (50%) | 10 (66.7%) |
| T stage | ||
| T1 | 5 (83.3%) | 11 (73.4%) |
| T2 | 1 (16.7%) | 2 (13.3%) |
| T3&T4 | 0 | 2 (13.3%) |